Physician profile
Hormoz Kianfar
NPI 1306008727
$18,739.32
in general payments reported to CMS, 2019-2025
50 companies · $5,047 in 2025
The $5,047 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,294 · 2020: $2,479 · 2021: $2,074 · 2022: $1,825 · 2023: $2,289 · 2024: $3,732 · 2025: $5,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,335 · Travel and Lodging: $1,733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,335.15 |
| Travel and Lodging | $1,732.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,651.16 | 2021-2025 | Symplicity G3, Hawkone, Ffrangio |
| Astrazeneca Pharmaceuticals LP | $2,041.22 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Boston Scientific Corporation | $1,556.67 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $1,452.98 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,354.21 | 2019-2025 | Jardiance |
| Abbott Laboratories | $1,203.20 | 2019-2025 | Aveir, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $928.91 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $913.01 | 2019-2025 | |
| Pfizer INC. | $778.15 | 2019-2025 | |
| Novo Nordisk INC | $598.31 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $515.82 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $479.92 | 2021-2025 | Verquvo, Belsomra |
| Shockwave Medical, INC | $456.29 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $413.00 | 2020-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $195.42 | 2019-2023 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $194.34 | 2019-2020 | |
| Avinger INC. | $190.56 | 2020-2023 | Pantheris |
| Lilly USA, LLC | $163.75 | 2023-2025 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $159.56 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $151.31 | 2019-2021 | |
| Abiomed | $150.64 | 2023-2025 | Impella |
| Astellas Pharma US INC | $139.52 | 2019-2021 | |
| Esperion Therapeutics, INC. | $120.56 | 2020-2025 | Nexletol |
| Heartflow, INC. | $91.08 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $78.29 | 2025 | Optimizer |
| Scpharmaceuticals INC. | $75.63 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $48.26 | 2024-2025 | Amvuttra, Onpattro |
| Cvrx, INC. | $48.05 | 2024 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $43.81 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $42.20 | 2021-2025 | |
| Arbor Pharmaceuticals, INC. | $41.24 | 2019-2021 | |
| Tactile Systems Technology INC | $40.27 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Kestra Medical Technology Services, INC. | $35.46 | 2024 | Assure Wcd |
| Edwards Lifesciences Corporation | $34.03 | 2022-2023 | |
| Lundbeck LLC | $33.93 | 2019-2020 | |
| Daiichi Sankyo INC. | $33.64 | 2022-2023 | Injectafer |
| Kiniksa Pharmaceuticals International, Plc | $32.21 | 2024 | Arcalyst |
| Chiesi USA, INC. | $30.39 | 2019-2025 | Kengreal |
| W. L. Gore & Associates, INC. | $29.55 | 2021 | |
| Endologix LLC | $23.92 | 2025 | Endocross Device, Torus Stent Graft System |
| Cashflow Solutions, LLC | $21.64 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Medicomp INC | $21.61 | 2024 | Telepatch Cardiac Monitor |
| Terumo Medical Corporation | $19.55 | 2024 | Metacross Otw, Glidewire |
| Kiniksa Pharmaceuticals, LTD. | $16.77 | 2023 | Arcalyst |
| Azurity Pharmaceuticals, INC. | $16.49 | 2024 | Edarbi |
| Medicure Pharma INC. | $15.43 | 2021 | |
| Veryan Medical Incorporated | $15.21 | 2021 | |
| Angiodynamics, INC. | $14.95 | 2024 | Auryon Laser System 100-120 Vac |
| Cardiva Medical, INC. | $14.71 | 2025 | Cardiva Vascade 6/7f Vcs |
| Shionogi INC | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hormoz Kianfar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.